Search

everythinglearnresearchcommunity

for

Search:↓

New treatments for male hypogonadism are effective and should be personalized.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

Targeting androgen receptors shows promise for treating triple-negative breast cancer, but more research is needed.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Male mice are more susceptible to autism-like changes from valproic acid than female mice.

Genetic defects in testosterone production can cause hormonal and developmental disorders, and more research is needed to understand androgen regulation and develop safer treatments.

GLP-1 receptor analogs may help improve metabolism and reproductive health in people with PCOS and obesity.

SARMs show promise but need more evidence to prove they're better than traditional androgens.

Testosterone affects blood pressure control and inflammation in male rats with endotoxic shock, and blocking certain hormones may help treat it.

PCOS is linked to diabetes and insulin resistance, and managing AGEs may help treat related symptoms.

Acupuncture may improve reproductive and metabolic functions in PCOS without negative side effects, but more research is needed to confirm its effectiveness.

VDR gene variations may affect carbohydrate metabolism in young women with hyperandrogenism.

Early detection and comprehensive treatment of PCOS are crucial due to its long-term health impacts and associated risks.

Gene mutations can cause problems in male genital development.

Sex hormone treatments can increase muscle mass in older adults but have inconsistent effects on muscle function and may carry cardiovascular risks.

New treatments for PCOS focus on insulin resistance and reducing testosterone levels, along with traditional hormone therapies.

Male pattern baldness is often genetic and linked to a hormone, with treatments like finasteride and minoxidil being effective for some men.

PCOS treatment should be personalized based on individual symptoms and health goals.

Certain gene variations may protect against skin issues and oxidative stress in women with PCOS.

Human sebaceous glands contain enzymes that affect androgen production and may influence sebum production and acne.

Sebaceous glands play a key role in skin health, immunity, and various skin diseases.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Barn owls with smaller black spots have higher testosterone levels, which might be due to genetic effects on hormone regulation rather than hormone effects on coloration.

The effect of GLP-1 RAs on erectile function is unclear and needs more research.

Dutasteride and minoxidil helped regrow hair in a woman with breast cancer.

Breast cancer hormone therapy can cause hair loss, which can be treated with daily applications of specific topical solutions like minoxidil and hydrocortisone butyrate.

Testosterone increases seizure risk through its conversion to specific neurosteroids.

Certain drugs can worsen hair loss in people prone to androgenetic alopecia.